Takeda wins definitive decision in Actos lawsuit
The decision upholds the validity of Takeda’s US patent covering pioglitazone hydrochloride, the active ingredient in Actos, which is used to control blood sugar levels in patients with
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.